More than 50% of Americans could have diabetes or pre-diabetes by 2020 at a cost of $3,350 billion over the next decade if current trends continue, according to new analysis by UnitedHealth Group’s Center for Health Reform & Modernization, but there are also practical solutions for slowing the trend.
New estimates show diabetes and pre-diabetes will account for an estimated 10% of total health care spending by the end of the decade at an annual cost of almost $500 billion - up from an estimated $194 billion this year.
The report, “The United States of Diabetes: Challenges and Opportunities in the Decade Ahead,” produced for this month's National Diabetes Awareness month, offers practical solutions that could improve health and life expectancy, while also saving up to $250 billion over the next 10 years, if programs to prevent and control diabetes are adopted broadly and scaled nationally. This figure includes $144 billion in potential savings to the federal government in Medicare, Medicaid and other public programs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze